BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Pulmonary Fibrosis Foundation Names Dr. Franck Rahaghi New President, CEO and Chief Medical Officer

  The Pulmonary Fibrosis Foundation announced Franck Rahaghi, MD, MHS, FCCP, as its incoming President, Chief Executive Officer and Chief Medical Officer, effective September 15.

  September 5, 2023

   · 

  3 min read
• Integra Therapeutics to present ex vivo and in vivo data for its FiCAT gene-writing platform at Advanced Therapies Europe congress

  The data shows the potential FiCAT technology holds, writing large and small genes to design safe, effective cell and gene therapies, and opens the door to the regulatory phase.

  September 5, 2023

   · 

  2 min read
• Defence’s Innovative Therapeutics Featured on Viewpoint with Dennis Quaid

  Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (“Defence” or the “Company”) a Canadian biopharmaceutical company developing novel immune-oncology vaccines

  September 5, 2023

   · 

  4 min read
• BioCapital

  Probiotic Study Shows Promise on Improving Innate Immunity

  BIO-CAT, Inc, | BIO-CAT announced today that a newly published study on the probiotic Bacillus subtilis MB40 revealed promising results leading to the reduction of Listeria.

  September 5, 2023

   · 

  1 min read
• Skye Bioscience to Present at H.C. Wainwright 25th Annual Global Investment Conference

  Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a pharmaceutical company developing proprietary medicines that modulate the endocannabinoid system to treat diseases with inflammatory, fibrotic, and metabolic processes

  September 5, 2023

   · 

  3 min read
• Satellos Expands Leadership Team with New CFO Appointment

  Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment

  September 5, 2023

   · 

  7 min read
• NervGen Pharma to Present on Its Drug Candidate NVG-291 and Spinal Cord Injury at the H.C. Wainwright 25th Annual Global Investment Conference

  NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage

  September 5, 2023

   · 

  5 min read
• Apotex Corp. Launches Brimonidine Tartrate Ophthalmic Solution, 0.1% in the United States

  Apotex Corp. has released its latest ophthalmic product in the United States, announcing today that brimonidine tartrate ophthalmic solution, 0.1% is now available.

  September 5, 2023

   · 

  1 min read
• Genetown

  PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences

  PHAXIAM Therapeutics, publishes its cash position as of June 30, 2023, and its financial calendar for the second half of 2023.

  September 5, 2023

   · 

  2 min read
• Biotech Bay

  CytomX Therapeutics to Present at Upcoming September 2023 Investor Conferences

  CytomX Therapeutics, Inc., a leader in the field of conditionally activated, localized biologics, announced that management will participate in the following investor conferences in September.

  September 5, 2023

   · 

  2 min read